Distinct Requirements for CD4 + T Cell Help for Immune Responses Induced by mRNA and Adenovirus‐Vector SARS‐CoV‐2 Vaccines
European Journal of Immunology · 2025-01 · 55 (1)
DOI: 10.1002/eji.202451142 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 27.11.2024. Verfasst von Lyn Yong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: SARS-CoV-2, CD4-Positive T-Lymphocytes, COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
CD4 + T cells have been established as central orchestrators of cellular and humoral immune responses to infection or vaccination. However, the need for CD4 + T cell help to generate primary CD8 + T cell responses is variable depending on the infectious agent or vaccine and yet consistently required for the recall of CD8 + T cell memory responses or antibody responses. Given the deployment of new vaccine platforms such as nucleoside‐modified mRNA vaccines, we sought to elucidate the requirement for CD4 + T cell help in the induction of cellular and antibody responses to mRNA and adenovirus (Ad)‐vectored vaccines against SARS‐CoV‐2. Using antibody‐mediated depletion of CD4 + T cells in a mouse immunization model, we observed that CD4 + T cell help was dispensable for both primary and secondary CD8 + T cell responses to the BNT162b2 and mRNA‐1273 mRNA vaccines but required for the AZD1222 Ad‐vectored vaccine. Nonetheless, CD4 + T cell help was needed by both mRNA and Ad‐vectored vaccine platforms for the generation of antibodies, demonstrating the centrality of CD4 + T cells in vaccine‐induced protective immunity against SARS‐CoV‐2. Ultimately, this highlights the shared and distinct regulation of humoral and cellular responses induced by these vaccine platforms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- Translational Gastroenterology and Liver Unit, Nuffield Department of Medicine-Experimental Medicine, University of Oxford, Oxford, UK.
- Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
ORCID-Profile: Lyn Yong, Nicholas M Provine
Förderung
- Wellcome Trust
- NIH HHS
- National Institutes of Health
Zitieren
APA
Yong, L., Hutchings, C., Barnes, E., Klenerman, P., & Provine, N. M. (2025). Distinct Requirements for CD4 + T Cell Help for Immune Responses Induced by mRNA and Adenovirus‐Vector SARS‐CoV‐2 Vaccines. European Journal of Immunology, 55(1). https://doi.org/10.1002/eji.202451142
Vancouver
Yong L, Hutchings C, Barnes E, Klenerman P, Provine NM. Distinct Requirements for CD4 + T Cell Help for Immune Responses Induced by mRNA and Adenovirus‐Vector SARS‐CoV‐2 Vaccines. European Journal of Immunology. 2025;55(1). doi:10.1002/eji.202451142
BibTeX
@article{Yong2025,
author = {Yong, Lyn and Hutchings, Claire and Barnes, Eleanor and Klenerman, Paul and Provine, Nicholas M},
title = {Distinct Requirements for CD4 + T Cell Help for Immune Responses Induced by mRNA and Adenovirus‐Vector SARS‐CoV‐2 Vaccines},
journal = {European Journal of Immunology},
year = {2025},
volume = {55},
number = {1},
doi = {10.1002/eji.202451142}
}
EUVIMED